Pharmacotherapists Need to Know Non-Drug Therapies

In silico drug repositioning: what we need to know.

Drug repositioning, exemplified by sildenafil and thalidomide, is a promising way to explore alternative indications for existing drugs. Recent research has shown that bioinformatics-based approaches have the potential to offer systematic insights into the complex relationships among drugs, targets and diseases necessary for successful repositioning. In this article, we propose the key bioinfor...

Comment. Drug utilization studies. The need to know the indication.

Gac Sanit. 2008;22(1):11-9 15. Monteagudo-Piqueras O, Sarría-Santamera A. Diferencias entre varones y mujeres respecto a la mortalidad hospitalaria y la utilización de procedimientos en el infarto agudo de miocardio. Gac Sanit. 2006;20:74-9. 16. Dreachslin J. Gender bias and the process of care. J Management Med. 1992;6:46-52. 17. Healy B. The Yentl syndrome. N Engl J Med. 1991;325:274-5. 18. M...

Drug interactions with warfarin: what clinicians need to know.

What you need to know about ... non-Hodgkin's lymphoma.

Adult liver transplantation: what non-specialists need to know.

TheUKhas approximately 6 000 surviving liver transplant recipients, and annually about 600 people with liver disease receive new livers. The post-transplant population is growing, since nearly 550 of those 600 patients are alive one year after the operation, and at least 300 are alive 20 years after. 3 We review liver transplantation for a non-specialist audience, with an emphasis on transplant...